Investment Firm
Overview
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Oct 15, 2019
Series B
Highlights
Location
Social
Participant Investors
6
Cyteir Therapeutics raised $40200000 on 2019-10-15 in Series B
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Company Funding History
5
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Oct 15, 2019 | Series B - Cyteir Therapeutics | 6 | - | 40.2M |
Feb 11, 2021 | Series C - Cyteir Therapeutics | 12 | - | 80.0M |
Jun 29, 2016 | Grant - Cyteir Therapeutics | 1 | - | 2.0M |
Nov 05, 2015 | Series A - Cyteir Therapeutics | 1 | - | 5.5M |
Recent Activity
There is no recent news or activity for this profile.